| Metric | შპს ნეოგენი | შპს ბათუმის ენდოკრინოლოგიის ცენტრი | შპს ლოტუსი |
|---|---|---|---|
| Growth | |||
| Revenue | ₾2.3m₾2.1m | ₾2.2m₾1.9m | ₾1.7m₾1.8m |
| Revenue growth | 8.1% | 14.1% | -3.3% |
| Profitability | |||
| EBITDA | ₾208k₾161k | ₾160k₾267k | ₾245k₾184k |
| EBITDA margin | 9.2%7.7% | 7.4%14.0% | 14.2%10.3% |
| Net profit | ₾178k₾135k | ₾159k₾265k | |
| ₾26k₾184k |
| Net margin | 7.9%6.5% | 7.3%13.9% | 1.5%10.3% |
| Balance sheet | |||
| Total assets | ₾369k₾355k | ₾2.1m₾2.2m | ₾2.6m₾2.5m |
| Total equity | ₾230k₾221k | ₾1.9m₾2.1m | ₾1.6m₾1.6m |
| ROE | 77.5%61.3% | 8.2%12.7% | 1.7%11.7% |